Clinical Trials
All Clinical Trials - Page 20 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05151016EARLY_Phase 1Unknown
Long-term Use of Mifepristone in the Treatment of Adenomyosis
Gonadorelin
- NCT05013229Phase 3Completed
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)
Semaglutide
- NCT05111912Phase 2Completed
Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity
Liraglutide
- NCT05144984Phase 2Completed
A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes
Semaglutide
- NCT05057546Phase 4Active Not Recruiting
Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study)
Gonadorelin
- NCT05132088Phase 3Completed
Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With Obesity
Semaglutide
- NCT05086445Phase 1Completed
A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus
Orforglipron
- NCT05110794Phase 1Completed
A Multiple-Dose Study of LY3502970 in Healthy Participants
Orforglipron
- NCT05166668N/ACompleted
Letrozole /GnRH Antagonist Protocol in Women Over 40 Years Undergoing ICSI Cycle
Gonadorelin
- NCT05071417Phase 3Unknown
Effect Of Semaglutide In Coronary Atheroma Plaque
Semaglutide
- NCT06182891N/ACompleted
Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
Dulaglutide
- NCT04958109Phase 1Completed
Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test
Kisspeptin
- NCT05159752Phase 2Unknown
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)
Afamelanotide
- NCT04199728Phase 1/Phase 2Completed
Use of a GLP-1R Agonist to Treat Opioid Use Disorder
Liraglutide
- NCT05034783EARLY_Phase 1Unknown
[68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients
Exenatide
- NCT05019846Phase 3Recruiting
SRT Versus SRT+ADT in Prostate Cancer
Gonadorelin
- NCT05051579Phase 2Completed
A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
Orforglipron
- NCT05051566Phase 1Completed
A Multiple Dose Study of LY3502970 in Healthy Participants
Orforglipron
- NCT05606471Phase 4Unknown
Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets
Semaglutide
- NCT05048719Phase 2Completed
A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus
Dulaglutide
- NCT04897802Phase 4Completed
Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
Exenatide
- NCT04817644Phase 1Completed
A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets
Semaglutide
- NCT04615871Phase 2Unknown
Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19
Semaglutide
- NCT05040971Phase 3Completed
Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes
Semaglutide
- NCT05046873Phase 1Completed
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
Semaglutide
- NCT04965506Phase 2Completed
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
Dulaglutide
- NCT05024032Phase 3Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)
Tirzepatide
- NCT04892199Phase 4Active Not Recruiting
Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
Semaglutide
- NCT05040087N/AActive Not Recruiting
Changing the Natural History of Type 2 Diabetes ("CHANGE" Study)
Semaglutide
- NCT05035082Phase 4Completed
A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)
Semaglutide
- NCT04963712EARLY_Phase 1Completed
Zadaxin and HIV-positive Patients With Immune Reconstitution Disorder
Thymosin-Alpha-1
- NCT05016882Phase 2Completed
Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)
Semaglutide
- NCT04964466N/AActive Not Recruiting
Release Kinetics in PRF Versus GEM21S With and Without Bone Substitutes: An In Vitro Analysis
Ghrp-6
- NCT04961996Phase 3Active Not Recruiting
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
Gonadorelin
- NCT04624672Phase 4Terminated
Treatment of GLP-1 for Diabetic Bariatric Patients
Semaglutide
- NCT05203133N/ACompleted
Effects of Acute Energy Deficit and Aerobic Exercise on Muscle Quality
Ghrp-6
- NCT05029622Phase 3Completed
A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty.
Gonadorelin
- NCT04971785Phase 2Completed
Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
Semaglutide
- NCT04862234Phase 4Terminated
Perioperative Stress Hyperglycemia in General and Vascular Surgery Patients
Dulaglutide
- NCT04989348N/ACompleted
Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol
Gonadorelin
- NCT04982575Phase 2Completed
Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes
Semaglutide
- NCT05003752Phase 1/Phase 2Active Not Recruiting
Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer
Gonadorelin
- NCT05220917N/AActive Not Recruiting
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
Semaglutide
- NCT04741074Phase 3Terminated
Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy
Semaglutide
- NCT04946617N/AUnknown
Chlorhexidine and Essential Oil Mouthwashes on Human Beta-Defensin 2 (hbD2) and Kathelicidin (LL-37) Saliva Levels
Ll-37
- NCT05225974Phase 1Completed
A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese Subjects
Liraglutide
- NCT04731272Phase 2Recruiting
GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
Dulaglutide
- NCT04969939Phase 2Completed
A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With Obesity
Semaglutide
- NCT04940078Phase 1Completed
A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or Obesity
Semaglutide
- NCT05161429N/AUnknown
BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes
Semaglutide